The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before signs or symptoms emerge. While these technological advancements signify remarkable progress in understanding neurodegenerative disorders, they have not https://geriatricpsychologistsnea88766.blogacep.com/43553770/the-enduring-value-of-cognitive-evaluation-for-more-mature-grownups